← Leaderboards
Andrea Hope Bild
University Of Utah
$7,326,006
Attributed
$10,359,268
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,898,009 · 7
By mechanism
U54$14,083,146 · 4
U01$5,089,823 · 2
R01$1,725,040 · 1
Top collaborators
- Joe W. Gray5 shared
- Stefanie S. Jeffrey5 shared
- William Evan Johnson5 shared
- Laura J Van'T Veer5 shared
Most similar at University Of Utah
Same institution · by research overlap
- Jonathan Eric Constance$2,718,439
- John M Hoffman$3,764,344
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeResistanceTumorPathway InteractionsMalignant NeoplasmsCancer PatientClinical TrialsMalignant Breast NeoplasmBaseEvolutionSignal TransductionBiological ModelsSamplingGenomicsNeoplastic CellResponsePharmaceutical PreparationsSignal PathwayCellsCancer CellHeterogeneitySystems BiologyResourcesOncogenic
Grant awards (38)
Mechanism of estrogen independent proliferation in ER+ breast cancer cells$577,234
U01 · FY2025 · CA · contact PI
Mechanism of estrogen independent proliferation in ER+ breast cancer cells$93,333
U01 · FY2025 · CA · contact PI
Mechanism of estrogen independent proliferation in ER+ breast cancer cells$742,035
U01 · FY2022 · CA · contact PI
Evolution of cancer cell phylogenies and phenotypes in breast cancer resistance$93,333
U01 · FY2022 · CA · contact PI
AKT as a resistance mechanism to cell cycle and endocrine therapies in ER+ breast cancer$93,333
U01 · FY2022 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$2,195,349
U54 · FY2021 · CA · contact PI
Mechanism of estrogen independent proliferation in ER+ breast cancer cells$596,232
U01 · FY2021 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$565,218
U54 · FY2021 · CA · contact PI
Administrative Core$146,782
U54 · FY2021 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$2,057,451
U54 · FY2020 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$557,126
U54 · FY2020 · CA · contact PI
Administrative Core$135,292
U54 · FY2020 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$1,999,948
U54 · FY2019 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$538,876
U54 · FY2019 · CA · contact PI
Administrative Core$124,537
U54 · FY2019 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$2,154,776
U54 · FY2018 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$562,927
U54 · FY2018 · CA · contact PI
Administrative Core$150,295
U54 · FY2018 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$125,000
U54 · FY2018 · CA · contact PI
Administrative Core$20,834
U54 · FY2018 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$20,833
U54 · FY2018 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$1,531,573
U54 · FY2017 · CA · contact PI
Combating Subclonal Evolution of Resistant Cancer Phenotypes$474,644
U54 · FY2017 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$399,809
U54 · FY2017 · CA · contact PI
Project-003$105,824
U54 · FY2017 · CA · contact PI
Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance$104,817
U54 · FY2017 · CA · contact PI
Administrative Core$76,183
U54 · FY2017 · CA · contact PI
Administrative Core$35,052
U54 · FY2017 · CA · contact PI
Integrative signaling models to decipher complex cancer phenotypes$514,480
U01 · FY2016 · CA · contact PI
Integrative signaling models to decipher complex cancer phenotypes$651,183
U01 · FY2015 · CA · contact PI
Integrative signaling models to decipher complex cancer phenotypes$551,268
U01 · FY2014 · CA · contact PI
Integrative signaling models to decipher complex cancer phenotypes$553,275
U01 · FY2013 · CA · contact PI
Integrative signaling models to decipher complex cancer phenotypes$624,117
U01 · FY2012 · CA · contact PI
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$381,030
R01 · FY2011 · GM · contact PI
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$384,756
R01 · FY2010 · GM · contact PI
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$168,650
R01 · FY2010 · GM · contact PI
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$389,056
R01 · FY2009 · GM · contact PI
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$401,548
R01 · FY2008 · GM · contact PI